Advertisement
Screener

BIOCEPT, INC. Forms 3, 4 and 5: Other

BIOCEPT, INC. Forms 3, 4 and 5: Other

Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 6 rows, 6 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.

  • 2021-07-20: Reporting owner Rubinstein Linda M; Form 3; Security No securities are beneficially owned; Transaction Holding.
  • 2021-07-20: Reporting owner Morales Antonino; Form 3; Security No securities are beneficially owned; Transaction Holding.
  • 2015-08-20: Reporting owner FOLETTA MARK G; Form 3; Security No securities are beneficially owned; Transaction Holding.
  • 2014-06-06: Reporting owner Trivedi Raaj; Form 3; Security No securities are beneficially owned; Transaction Holding.
Transaction dateReporting ownerFormSecurityTransactionSharesPricePrice that dayFiling
2021-07-20
holding as of filing
Rubinstein Linda M
Director
3No securities are beneficially owned
Non-derivative · Direct
Holding
0 owned after
no price filed2021-07-20
2021-07-20
holding as of filing
Morales Antonino
Director
3No securities are beneficially owned
Non-derivative · Direct
Holding
0 owned after
no price filed2021-07-20
2015-08-20
holding as of filing
FOLETTA MARK G
Officer (Interim CFO)
3No securities are beneficially owned
Non-derivative · Direct
Holding
0 owned after
no price filed2015-08-20
2014-06-06
holding as of filing
Trivedi Raaj
Officer (VP, COMMERCIAL OPERATIONS)
3No securities are beneficially owned
Non-derivative · Direct
Holding
0 owned after
no price filed2014-06-06
2014-02-10HALE DAVID F
Director, Officer (CHAIRMAN)
4Issuer?s repurchase right (obligation to sell)
Derivative · Direct · (m)
E Expiration of short derivative position−10,204
0 owned after
$4.622014-02-12
2014-02-04
holding as of filing
HALE DAVID F
Director, Officer (EXECUTIVE CHAIRMAN)
3Issuer?s repurchase right (obligation to sell)
Derivative · Direct · (m)
Holding$4.62
exercise price
2014-02-04